96 related articles for article (PubMed ID: 3967262)
21. Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancers.
Houghton PJ; Cheshire PJ; Hallman JC; Gross JL; McRipley RJ; Sun JH; Behrens CH; Dexter DL; Houghton JA
Cancer Chemother Pharmacol; 1994; 33(4):265-72. PubMed ID: 8281618
[TBL] [Abstract][Full Text] [Related]
22. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
23. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Clutterbuck RD; Millar JL; McElwain TJ
Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
25. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F
Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcoma.
Houghton PJ; Tharp R; Houghton JA; Holland JF; Bekesi JG
Cancer Chemother Pharmacol; 1988; 22(3):201-4. PubMed ID: 3409455
[TBL] [Abstract][Full Text] [Related]
27. Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration.
Houghton JA; Meyer WH; Houghton PJ
Cancer Treat Rep; 1987; 71(7-8):717-21. PubMed ID: 3607783
[TBL] [Abstract][Full Text] [Related]
28. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
Caffrey PB; Zhang Y; Frenkel GD
Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
[TBL] [Abstract][Full Text] [Related]
29. Experimental chemotherapy of human medulloblastoma with classical alkylators.
Friedman HS; Colvin OM; Ludeman SM; Schold SC; Boyd VL; Mulhbaier LH; Bigner DD
Cancer Res; 1986 Jun; 46(6):2827-33. PubMed ID: 3698009
[TBL] [Abstract][Full Text] [Related]
30. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
Mattern J; Wayss K; Volm M
J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
[TBL] [Abstract][Full Text] [Related]
31. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
[TBL] [Abstract][Full Text] [Related]
32. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of in vitro clonogenic assay data with in vivo chemosensitivity of human rhabdomyosarcoma xenografts].
Mizuno Y; Satomura K; Tanaka K; Tanigawa N
Nihon Geka Hokan; 1985 Nov; 54(6):441-7. PubMed ID: 3834862
[No Abstract] [Full Text] [Related]
34. Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays.
Pawlik CA; Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Danks MK
Clin Cancer Res; 1998 Aug; 4(8):1995-2002. PubMed ID: 9717830
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor binding protein-6 and CCI-779, an ester analogue of rapamycin, additively inhibit rhabdomyosarcoma growth.
Gallicchio MA; van Sinderen M; Bach LA
Horm Metab Res; 2003; 35(11-12):822-7. PubMed ID: 14710364
[TBL] [Abstract][Full Text] [Related]
36. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
37. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
38. The pediatric preclinical testing program: description of models and early testing results.
Houghton PJ; Morton CL; Tucker C; Payne D; Favours E; Cole C; Gorlick R; Kolb EA; Zhang W; Lock R; Carol H; Tajbakhsh M; Reynolds CP; Maris JM; Courtright J; Keir ST; Friedman HS; Stopford C; Zeidner J; Wu J; Liu T; Billups CA; Khan J; Ansher S; Zhang J; Smith MA
Pediatr Blood Cancer; 2007 Dec; 49(7):928-40. PubMed ID: 17066459
[TBL] [Abstract][Full Text] [Related]
39. Xenografts of human bladder cancer in immune-deprived mice.
Kovnat A; Armitage M; Tannock I
Cancer Res; 1982 Sep; 42(9):3696-703. PubMed ID: 7049361
[TBL] [Abstract][Full Text] [Related]
40. Rhabdomyosarcoma. From the laboratory to the clinic.
Houghton PJ; Shapiro DN; Houghton JA
Pediatr Clin North Am; 1991 Apr; 38(2):349-64. PubMed ID: 2006081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]